Published on
September 23, 2025
- 17:25 GMT
REVA Medical Announces Positive 36-Month MOTIV Bioresorbable Scaffold Study Results for Below-the-Knee Artery Disease
REVA Medical's MOTIV® Bioresorbable Scaffold shows positive 36-month results in European BTK study, published in Cardiovascular and Interventional Radiology. SAN DIEGO, CA, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- REVA Medical, LLC, a …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
